RT Journal Article
SR Electronic
T1 Recurrent vaginal candidosis: prospective study of effectiveness of maintenance miconazole treatment.
JF Genitourinary Medicine
JO Genitourin Med
FD BMJ Publishing Group Ltd
SP 124
OP 127
DO 10.1136/sti.64.2.124
VO 64
IS 2
A1 M J Balsdon
A1 J M Tobin
YR 1988
UL http://sti.bmj.com/content/64/2/124.abstract
AB In a prospective study, 100 women with recurrent vaginal candidosis were treated with miconazole, using two 100 mg vaginal pessaries a day for one week, then one pessary twice a week for three months followed by one pessary a week for a further three months. Fifty four women elected to continue using one pessary a week for longer than six months. Symptomatic vaginal candidosis did not occur in any patient during regular maintenance treatment. Of the 46 women who discontinued treatment before six months, however, 22 had a recurrence. Maintenance prophylactic treatment with miconazole pessaries appears to be an acceptable and effective method of preventing recurrent episodes of vaginal candidosis.